ALK and lung carcinoma: To explore the molecular mechanisms underlying treatment-induced adaptive survival of ALK-rearranged lung cancer cells, we performed functional genomic CRISPR KO screen using small guide RNA (sgRNA) libraries (Fig. 1e).